ROZANOLIXIZUMAB IN GENERALIZED MYASTHENIA GRAVIS: RESPONDER ANALYSES FROM THE RANDOMIZED PHASE 3 MYCARING STUDY

被引：0
|
作者：
Bril, Vera
Druzdz, Artur
Grosskreutz, Julian
Habib, Ali
Mantegazza, Renato
Sacconi, Sabrina
Utsugisawa, Kimiaki
Vissing, John
Vu, Tuan
Boehnlein, Marion
Bozorg, Ali
Gayfieva, Maryam
Woltering, Franz
Kaminski, Henry
机构：
来源：
MUSCLE & NERVE | 2022年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
204
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [1] Efficacy of Rozanolixizumab in Generalized Myasthenia Gravis: Subgroup Analyses from the Randomized Phase 3 MycarinG Study
    Vu, Tuan
    Druzdz, Artur
    Grosskreutz, Julian
    Habib, Ali A.
    Kaminski, Henry J.
    Mantegazza, Renato
    Utsugisawa, Kimiaki
    Vissing, John
    Beau-Lejdstrom, Raphaelle
    Boehnlein, Marion
    Gasalla, Teresa
    Grimson, Fiona
    Tarancon, Thais
    Bril, Vera
    [J]. NEUROLOGY, 2023, 100 (17)
  • [2] Response to rozanolixizumab in patients with generalized myasthenia gravis (gMG) from the Phase 3 MycarinG study
    Vissing, J.
    Druzdz, A.
    Grosskreutz, J.
    Habib, A.
    Mantegazza, R.
    Utsugisawa, K.
    Vu, T.
    Grimson, F.
    Lejdstrom, R. Beau
    Pulido-Valdeolivas, I.
    Tarancon, T.
    Bril, V.
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 : S178 - S179
  • [3] EFFICACY OF ROZANOLIXIZUMAB IN MUSCLE SPECIFIC KINASE ANTIBODY-POSITIVE GENERALIZED MYASTHENIA GRAVIS: OUTCOMES FROM THE RANDOMIZED, PHASE 3 MYCARING STUDY
    Habib, Ali
    Kaminski, Henry
    Druzdz, Artur
    Grosskreutz, Julian
    Mantegazza, Renato
    Sacconi, Sabrina
    Utsugisawa, Kimiaki
    Vissing, John
    Vu, Tuan
    Boehnlein, Marion
    Greve, Bernhard
    Woltering, Franz
    Bril, Vera
    [J]. MUSCLE & NERVE, 2022, 66 : S133 - S134
  • [4] EFFICACY AND SAFETY OF ROZANOLIXIZUMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY (MYCARING)
    Bril, Vera
    Druzdz, Artur
    Grosskreutz, Julian
    Habib, Ali A.
    Mantegazza, Renato
    Sacconi, Sabrina
    Utsugisawa, Kimiaki
    Vissing, John
    Vu, Tuan
    Boehnlein, Marion
    Woltering, Franz
    Bozorg, Ali
    Gayfieva, Maryam
    Kaminski, Henry
    [J]. MUSCLE & NERVE, 2022, 65 : S35 - S35
  • [5] Rozanolixizumab in muscle-specific kinase autoantibody-positive myasthenia gravis: Further analyses from MycarinG study
    Sacconi, S.
    Habib, A.
    Antonini, G.
    Cortes-Vicente, E.
    Grosskreutz, J.
    Mahuwala, Z.
    Mantegazza, R.
    Pascuzzi, R.
    Utsugisawa, K.
    Vissing, J.
    Vu, T.
    Wiendl, H.
    Boehnlein, M.
    Tarancon, T.
    Grimson, F.
    Bril, V.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 570 - 571
  • [6] SAFETY AND TOLERABILITY OF ROZANOLIXIZUMAB IN THE RANDOMIZED PHASE-3 MYCARING STUDY
    Vu, Tuan
    Kaminski, Henry
    Druzdz, Artur
    Grosskreutz, Julian
    Habib, Ali
    Mantegazza, Renato
    Sacconi, Sabrina
    Utsugisawa, Kimiaki
    Vissing, John
    Boehnlein, Marion
    Greve, Bernhard
    Woltering, Franz
    Gayfieva, Maryam
    Bril, Vera
    [J]. MUSCLE & NERVE, 2022, 66 : S136 - S136
  • [7] Rozanolixizumab responder and minimal symptom expression rates in generalized myasthenia gravis: Pooled phase 3 and extension studies
    Bril, Vera
    Vissing, John
    Druzdz, Artur
    Grosskreutz, Julian
    Habib, Ali A.
    Mantegazza, Renato
    Sacconi, Sabrina
    Utsugisawa, Kimiaki
    Vu, Tuan
    Boehnlein, Marion
    Greve, Bernhard
    Woltering, Franz
    Gayfieva, Maryam
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [8] Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
    Bril, Vera
    Druzdz, Artur
    Grosskreutz, Julian
    Habib, Ali A.
    Mantegazza, Renato
    Sacconi, Sabrina
    Utsugisawa, Kimiaki
    Vissing, John
    Vu, Tuan
    Boehnlein, Marion
    Bozorg, Ali
    Gayfieva, Maryam
    Greve, Bernhard
    Woltering, Franz
    Kaminski, Henry J.
    [J]. LANCET NEUROLOGY, 2023, 22 (05): : 383 - 394
  • [9] PATIENT-REPORTED AND QUALITY OF LIFE OUTCOMES FROM MYCARING, A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL OF ROZANOLIXIZUMAB IN GENERALISED MYASTHENIA GRAVIS
    Habib, Ali A.
    Druzdz, Artur
    Grosskreutz, Julian
    Kaminski, Henry
    Mantegazza, Renato
    Sacconi, Sabrina
    Utsugisawa, Kimiaki
    Vissing, John
    Vu, Tuan
    Morel, Thomas
    Boehnlein, Marion
    Woltering, Franz
    Bozorg, Ali
    Gayfieva, Maryam
    Bril, Vera
    [J]. MUSCLE & NERVE, 2022, 65 : S19 - S20
  • [10] Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial
    Klein, Friederike
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2022, 90 (09) : 386 - +
12345